Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2012
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/29/2012US20120077797 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
03/29/2012US20120077796 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077794 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077775 Macrocyclic compounds useful as inhibitors of kinases and hsp90
03/29/2012US20120077770 Methods of Diagnosing and Treating Multiple Sclerosis
03/29/2012US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE)
03/29/2012US20120077754 Copolymer-1 improvements in compositions of copolymers
03/29/2012US20120077753 Jnk inhibitors for use in treating spinal muscular atrophy
03/29/2012US20120077752 Composition for improving brain function and method for improving brain function
03/29/2012US20120077751 Methods for modulating neuronal responses
03/29/2012US20120077747 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
03/29/2012US20120077744 Steroid-sparing methods of treating brain edema
03/29/2012US20120077741 Treatment of Central Nervous System Disorders
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120076878 Compositions and methods for the prevention and treatment of brain diseases and conditions
03/29/2012US20120076875 Herbal medicinal composition and extract thereof for inducing proliferation of cranial nerve cells and method of manufacturing the same
03/29/2012US20120076869 Methods of treating dementia using omentum
03/29/2012US20120076831 Compositions and methods for induction of antigen-specific tolerance
03/29/2012US20120076823 Vector
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076791 Methods Of Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome
03/29/2012US20120076785 Method for inhibiting neurodegeneration
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076761 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
03/29/2012US20120076759 Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
03/29/2012US20120076734 Radiopaque antibiotic dental paste and uses thereof
03/29/2012US20120076732 Phosphodiesterase inhibitors and uses thereof
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012CA2812570A1 Controlled release formulations of opioids
03/29/2012CA2812378A1 Fused tricyclic compounds as adenosine receptor antagonist
03/29/2012CA2812299A1 Administration of serine protease inhibitors to the stomach
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811714A1 Imidazotriazinone compounds
03/29/2012CA2810706A1 Substituted amide compound
03/29/2012CA2810356A1 Buprenorphine analogs
03/29/2012CA2809675A1 Monohydrate of an azaadamantane derivative
03/29/2012CA2809646A1 5.alpha.-androstane-3.beta.,5,6.beta.-triol injection and preparation method therefor
03/29/2012CA2809557A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
03/29/2012CA2809217A1 Pyrimidones for treatment of potassium channel related diseases
03/29/2012CA2807904A1 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace)
03/28/2012EP2433939A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
03/28/2012EP2433938A1 Therapeutic agent for motor disorders
03/28/2012EP2433937A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433936A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433935A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433643A1 Medicaments comprising triptan and botulinum toxin for use in treating headache
03/28/2012EP2433635A1 PAK Modulators
03/28/2012EP2433630A1 Self-emulsifying composition of 3 fatty acid
03/28/2012EP2432784A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
03/28/2012EP2432783A1 Modulators of 5-ht receptors and methods of use thereof
03/28/2012EP2432778A1 Process for the preparation of ibodutant (men15596) and related intermediates
03/28/2012EP2432776A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
03/28/2012EP2432769A1 N-PHENYL-(PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENYL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR& xA;
03/28/2012EP2432765A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
03/28/2012EP2432491A2 Means and methods for counteracting polyq expansion disorders
03/28/2012EP2432483A1 Composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases
03/28/2012EP2432481A2 Cell therapy for brain tissue damage
03/28/2012EP2432469A1 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
03/28/2012EP2432462A2 Endoxifen methods and compositions in the treatment of mammalian diseases
03/28/2012EP2432454A1 Compositions for continuous administration of dopa decarboxylase inhibitors
03/28/2012EP2432328A1 Fat blends and uses thereof
03/28/2012EP2432319A1 Method of treatment of obsessive compulsive disorder with ondansetron
03/28/2012EP2297148B8 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
03/28/2012EP2252612B1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP1859041B1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
03/28/2012EP1799685B1 Polymorphic forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
03/28/2012EP1453508B1 Tempamine compositions and use against cellular oxidative damage
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012EP1284711B2 Process for making a blister package containing topiramate tablets
03/28/2012EP1272197B2 Combination of lecithin with ascorbic acid
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN1954862B Syrup for treating headache
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
03/28/2012CN102395583A Isoxazole derivatives
03/28/2012CN102395577A Diazepinedione derivative
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395562A Novel p2x7r antagonists and their use
03/28/2012CN102395558A Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
03/28/2012CN102395371A 5-ht4 receptor agonist compounds for treatment of cognitive disorders
03/28/2012CN102395366A Method of decreasing pro-adam10 secretase and/or beta secretase levels
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN102391359A Histone deacetylase inhibitors (HDACIs), synthetic method thereof and pharmaceutical purposes thereof
03/28/2012CN102391305A Phosphate disodium salt hydrate of propofol hydroxyacid ester and preparation method and application thereof
03/28/2012CN102391271A Improved method for making analgesics
03/28/2012CN102391258A Amino-substituted flavone compound and preparation and use thereof
03/28/2012CN102391180A Sulfydryl-containing tacrine derivative and preparation method and application thereof
03/28/2012CN102391137A Water-soluble amino acid ester derivative of propofol and application thereof
03/28/2012CN102391119A Preparation of high purity chlorogenic acid preparation and clinical application thereof
03/28/2012CN102389556A Chinese medical drug abstinence tablet and preparation process thereof
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1833